Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland · Delayed Price · Currency is CHF 54.70
-0.30 (-0.55%)
Jul 10, 2026, 5:30 PM CET
Basilea Pharmaceutica AG Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Basilea Pharmaceutica AG stock has a consensus rating of "Buy" and an average price target of CHF 89.90. The average 1-year stock price forecast is 64.35% higher than the current stock price, while the lowest is CHF 59.40 (+8.59%) and the highest is CHF 120.00 (+119.38%).
Price Target: CHF 89.90 (+64.35%)
Analyst Consensus: Buy
* Price targets were last updated on Apr 13, 2026.
Analyst Ratings
The average analyst rating for Basilea Pharmaceutica AG stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Kepler Capital | Kepler Capital | Buy Maintains CHF 69.00 → CHF 70.00 | Buy | Maintains | CHF 69.00 → CHF 70.00 | +27.97% | Apr 13, 2026 |
Financial Forecast
Revenue This Year
258.73M
from 232.38M
Increased by 11.34%
Revenue Next Year
267.47M
from 258.73M
Increased by 3.38%
EPS This Year
4.84
from 3.14
Increased by 54.04%
EPS Next Year
4.13
from 4.84
Decreased by -14.55%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CHF.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 273.1M | ||
| Avg | 258.7M | ||
| Low | 242.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 17.5% | ||
| Avg | 11.3% | ||
| Low | 4.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.97 | ||
| Avg | 4.84 | ||
| Low | 3.77 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 122.0% | ||
| Avg | 54.0% | ||
| Low | 20.0% |